US Patent 7163933 Treating agent for Paget's disease of bone
Patent 7163933 was granted and assigned to Teijin on January, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Atsushi Imaizumi0
G. David Roodman0
Kazuya Takenouchi0
Noriyoshi Kurihara0
Sakamuri V. Reddy0
Seiichi Ishizuka0
Yasuhiro Oue0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+183 characters)
Article
Patent abstract
To obtain a treating agent for Paget's disease of bone, there is provided a method of inhibiting expression of general transcription factor of steroid hormone receptor.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07163933 Treating agent for Paget's disease of bone US Patent 7163933 Treating agent for Paget's disease of bone
Infobox
Patent Number
071639330
Patent Number
71639330
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071639330
Date of Patent
January 16, 2007
0Patent Application Number
103697520
Date Filed
February 21, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07163933 Treating agent for Paget's disease of bone
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07163933
Date of patent
January 16, 2007
Patent application number
10369752
Date Filed
February 21, 2003
Patent primary examiner
Find more entities like US Patent 7163933 Treating agent for Paget's disease of bone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.